Trial NCT02374567

View at ClinicalTrials.gov 
Org. Study IDs: GAP-2014

Last trial update was posted on 2018-02-28

MeSH Interventions

Acamprosate Agomelatine Alprazolam Amisulpride Amitriptyline Aripiprazole Benperidol Biperiden Bromazepam Bromperidol Brotizolam Bupropion Buspirone Carbamazepine Chloral Hydrate Chlormethiazole Chlorprothixene Citalopram Clobazam Clomipramine Clonazepam Clopenthixol Clozapine Diazepam Diphenhydramine Donepezil Doxepin Duloxetine Hydrochloride Escitalopram Fluoxetine Flupenthixol Flupenthixol decanoate Fluphenazine Fluphenazine depot Fluphenazine enanthate Flurazepam Fluspirilene Fluvoxamine Gabapentin Galantamine Haloperidol Hydroxyzine Imipramine Lacosamide Lamotrigine Levetiracetam Lorazepam Lormetazepam Maprotiline Melatonin Memantine Methotrimeprazine Mianserin Midazolam Mirtazapine Moclobemide Nicergoline Nitrazepam Nortriptyline Olanzapine Opipramol Oxazepam Oxcarbazepine Paliperidone Palmitate Paroxetine Perazine Perphenazine Phenobarbital Phenytoin Pimozide Pipamperone Piracetam Pregabalin Promethazine Quetiapine Fumarate Reboxetine Risperidone Rivastigmine Sertindole Sertraline Sulpiride Temazepam Thioridazine Tiapride Hydrochloride Topiramate Tranylcypromine Trazodone Triazolam Trimipramine Valproic Acid Venlafaxine Hydrochloride Zaleplon Ziprasidone Zolpidem Zopiclone

MeSH Conditions

Anxiety Disorders Psychophysiologic Disorders Schizophrenia Somatoform Disorders

Other Conditions

Dementia Depression Psychosomatic Disorders

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID